AGRANULOCYTOSIS ASSOCIATED WITH PROMAZINE ADMINISTRATION: REPORT OF THREE CASES
- 1 February 1958
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 48 (2) , 372-379
- https://doi.org/10.7326/0003-4819-48-2-372
Abstract
While agranulocytosis has been reported with chlorpromazine, only two previous reports of its occurrence with use of promazine have appeared to date. This paper describes 3 more such cases. Dosages ranged from 2.75 g in 31 days to 11.7 g intermittently over a 6-month period. Presenting symptoms included fever, cough, sore throat and diarrhea. Lowest white cell count ranged from 200 to 900/mm3. Therapy included penicillin, streptomycin and dihydro-streptomycin, broad spectrum antibiotics, nystatin, and prednisone. One patient expired from a monilial infection. The others recovered. Possible mechanisms are discussed, with high dosages and prolonged exposures favoring a possible toxic mode of action. Therapeutic measures are mentioned, and the literature briefly reviewed.Keywords
This publication has 9 references indexed in Scilit:
- Agranulocytosis after Promazine TherapyNew England Journal of Medicine, 1957
- CASE REPORTSAmerican Journal of Psychiatry, 1957
- FATAL AGRANULOCYTOSIS OCCURRING DURING PROMAZINE (SPARINE) THERAPYJAMA, 1956
- Agranulocytosis Associated with Chlorpromazine TherapyNew England Journal of Medicine, 1956
- MANAGEMENT OF ACUTELY DISTURBED PATIENTS WITH PROMAZINE (SPARINE)JAMA, 1956
- TREATMENT OF ACUTE ALCOHOLISM WITH PROMAZINE (SPARINE)JAMA, 1956
- COUNCIL ON PHARMACY AND CHEMISTRYJAMA, 1956
- Hemotoxic Reactions to DrugsPostgraduate Medicine, 1954
- LeukoagglutininsBlood, 1954